Toxic Neuropathies Associated with Pharmaceutic and Industrial Agents

Neurologic Clinics

Volumn 25, Issue 1, 2007, Pages 257-276

  London, Zachary ^a   Albers, James W ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLAMIDE; ALCOHOL; AMIODARONE; ARSENIC; CISPLATIN; COLCHICINE; DAPSONE; HEXANE; LEAD; LITHIUM; MERCURY; METRONIDAZOLE; NITROFURANTOIN; NITROUS OXIDE; ORGANOPHOSPHATE PESTICIDE; PHENYTOIN; PYRIDOXINE; SAXITOXIN; TETRODOTOXIN; THALIDOMIDE; THALLIUM; TOLUENE; TRICHLOROETHYLENE; TRYPTOPHAN; VINCRISTINE;

BRAIN DISEASE; BRAIN PSEUDOTUMOR; CLINICAL FEATURE; EXTRAPYRAMIDAL SYNDROME; HUMAN; MONONEUROPATHY MULTIPLEX; MOTOR NEUROPATHY; MYOPATHY; NERVE CONDUCTION DISORDER; NEUROPATHY; NEUROTOXICITY; OPTIC NERVE DISEASE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; SENSORY NEUROPATHY; SYMPTOMATOLOGY; TREMOR;

AMIODARONE; ANTINEOPLASTIC AGENTS; ARSENIC; DRUG THERAPY; HAZARDOUS SUBSTANCES; HUMANS; INDUSTRY; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM DISEASES; PHOSPHORIC ACID ESTERS; THALLIUM; VASODILATOR AGENTS; VINCRISTINE; VITAMIN B 12;

EID: 33847122898     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2006.10.001     Document Type: Review

References (117)

1. Schaumburg H.H., and Spencer P.S. Recognizing neurotoxic disease. Neurology 37 (1987) 276-278
2. Albers J.W. Clinical neurophysiology of generalized polyneuropathy. J Clin Neurophysiol 10 (1993) 149-166
3. Feldman R.G., Niles C.A., Kelly-Hayes M., et al. Peripheral neuropathy in arsenic smelter workers. Neurology 29 (1979) 939-944
4. Kreiss K., Zack M.M., Landrigan P.J., et al. Neurologic evaluation of a population exposed to arsenic in Alaskan well water. Arch Environ Health 38 (1983) 116-121
5. Mukherjee S.C., Rahman M.M., Chowdhury U.K., et al. Neuropathy in arsenic toxicity from groundwater arsenic contamination in West Bengal, India. J Environ Sci Health [A] 38 (2003) 165-183
6. Greenberg S.A. Acute demyelinating polyneuropathy with arsenic ingestion. Muscle Nerve 19 (1996) 1611-1613
7. Jenkins R.B. Inorganic arsenic and the nervous system. Brain 89 (1966) 479-498
8. Chhuttani P.N., Chawla L.S., and Sharma T.D. Arsenical neuropathy. Neurology 17 (1967) 269-274
9. Ghariani M., Adrien M.L., Raucoules M., et al. [Subacute arsenic poisoning]. Ann Fr Anesth Reanim 10 (1991) 304-307 [in French]
10. Donofrio P.D., Wilbourn A.J., Albers J.W., et al. Acute arsenic intoxication presenting as Guillain-Barre-like syndrome. Muscle Nerve 10 (1987) 114-120
11. Bromberg M.B., and Albers J.W. Patterns of sensory nerve conduction abnormalities in demyelinating and axonal peripheral nerve disorders. Muscle Nerve 16 (1993) 262-266
12. Landrigan P.J. Arsenic-state of the art. Am J Ind Med 2 (1981) 5-14
13. Valenzuela O.L., Borja-Aburto V.H., Garcia-Vargas G.G., et al. Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic. Environ Health Perspect 113 (2005) 250-254
14. Wax P.M., and Thornton C.A. Recovery from severe arsenic-induced peripheral neuropathy with 2,3-dimercapto-1-propanesulphonic acid. J Toxicol Clin Toxicol 38 (2000) 777-780
15. Heyman A., Pfeiffer Jr. J.B., Willett R.W., et al. Peripheral neuropathy caused by arsenical intoxication; a study of 41 cases with observations on the effects of BAL (2, 3, dimercapto-propanol). N Engl J Med 254 (1956) 401-409
16. Kuwabara S., Kai M.R., Nagase H., et al. n-Hexane neuropathy caused by addictive inhalation: clinical and electrophysiological features. Eur Neurol 41 (1999) 163-167
17. Kuwabara S., Nakajima M., Tsuboi Y., et al. Multifocal conduction block in n-hexane neuropathy. Muscle Nerve 16 (1993) 1416-1417
18. Krasavage W.J., O'Donoghue J.L., DiVincenzo G.D., et al. The relative neurotoxicity of methyl-n-butyl ketone, n-hexane and their metabolites. Toxicol Appl Pharmacol 52 (1980) 433-441
19. Smith A.G., and Albers J.W. n-Hexane neuropathy due to rubber cement sniffing. Muscle Nerve 20 (1997) 1445-1450
20. Paulson G.W., and Waylonis G.W. Polyneuropathy due to n-hexane. Arch Intern Med 136 (1976) 880-882
21. Ruff R.L., Petito C.K., and Acheson L.S. Neuropathy associated with chronic low level exposure to n-hexane. Clin Toxicol 18 (1981) 515-519
22. Issever H., Malat G., Sabuncu H.H., et al. Impairment of colour vision in patients with n-hexane exposure-dependent toxic polyneuropathy. Occup Med (Lond) 52 (2002) 183-186
23. Korobkin R., Asbury A.K., Sumner A.J., et al. Glue-sniffing neuropathy. Arch Neurol 32 (1975) 158-162
24. Spencer P.S., and Schaumburg H.H. Organic solvent neurotoxicity. Facts and research needs. Scand J Work Environ Health 11 Suppl 1 (1985) 53-60
25. Griffin J.W. Hexacarbon neurotoxicity. Neurobehav Toxicol Teratol 3 (1981) 437-444
26. Yokoyama K., Feldman R.G., Sax D.S., et al. Relation of distribution of conduction velocities to nerve biopsy findings in n-hexane poisoning. Muscle Nerve 13 (1990) 314-320
27. Chang C.M., Yu C.W., Fong K.Y., et al. N-hexane neuropathy in offset printers. J Neurol Neurosurg Psychiatry 56 (1993) 538-542
28. Kuang S., Huang H., Liu H., et al. [A clinical analysis of 102 cases of chronic n-hexane intoxication]. Zhonghua Nei Ke Za Zhi 40 (2001) 329-331 [in Chinese]
29. Besser R., Treese N., Bohl J., et al. [Clinical, neurophysiologic and biopsy findings in neurotoxic amiodarone syndrome]. Med Klin 89 (1994) 367-372 [in German]
30. Meier C., Kauer B., Muller U., et al. Neuromyopathy during chronic amiodarone treatment. A case report. J Neurol 220 (1979) 231-239
31. Lemaire J.F., Autret A., Biziere K., et al. Amiodaron neuropathy: further arguments for human drug-induced neurolipidosis. Eur Neurol 21 (1982) 65-68
32. Martinez-Arizala A., Sobol S.M., McCarty G.E., et al. Amiodarone neuropathy. Neurology 33 (1983) 643-645
33. Charness M.E., Morady F., and Scheinman M.M. Frequent neurologic toxicity associated with amiodarone therapy. Neurology 34 (1984) 669-671
34. Pellissier J.F., Pouget J., Cros D., et al. Peripheral neuropathy induced by amiodarone chlorhydrate. A clinicopathological study. J Neurol Sci 63 (1984) 251-266
35. Anderson N.E., Lynch N.M., and O'Brien K.P. Disabling neurological complications of amiodarone. Aust N Z J Med 15 (1985) 300-304
36. Abarbanel J.M., Osiman A., Frisher S., et al. Peripheral neuropathy and cerebellar syndrome associated with amiodarone therapy. Isr J Med Sci 23 (1987) 893-895
37. Fernando Roth R., Itabashi H., Louie J., et al. Amiodarone toxicity: myopathy and neuropathy. Am Heart J 119 (1990) 1223-1225
38. Pulipaka U.L.D., and Omalu B. Amiodarone-induced neuromyopathy: three cases and a review of the literature. J Clin Neuromusc Dis 3 (2002) 97-105
39. Palakurthy P.R., Iyer V., and Meckler R.J. Unusual neurotoxicity associated with amiodarone therapy. Arch Intern Med 147 (1987) 881-884
40. Jacobs J.M., and Costa-Jussa F.R. The pathology of amiodarone neurotoxicity. II. Peripheral neuropathy in man. Brain 108 Pt 3 (1985) 753-769
41. Morgan J.P. The Jamaica ginger paralysis. JAMA 248 (1982) 1864-1867
42. Morgan J.P., and Penovich P. Jamaica ginger paralysis. Forty-seven-year follow-up. Arch Neurol 35 (1978) 530-532
43. Woolf A.D. Ginger Jake and the blues: a tragic song of poisoning. Vet Hum Toxicol 37 (1995) 252-254
44. Eyer P. Neuropsychopathological changes by organophosphorus compounds-a review. Hum Exp Toxicol 14 (1995) 857-864
45. Konno N. [Neurotoxicity of organophosphorus and dithiocarbamate compounds]. Nippon Eiseigaku Zasshi 57 (2003) 645-654 [in Japanese]
46. Barrett D.S., and Oehme F.W. The effect of a single oral dose of tri-o-cresyl phosphate on neurotoxic esterase and acetylcholinesterase activities in the central nervous system, erythrocytes and plasma. Vet Hum Toxicol 36 (1994) 1-4
47. Senanayake N., and Johnson M.K. Acute polyneuropathy after poisoning by a new organophosphate insecticide. N Engl J Med 306 (1982) 155-157
48. Van den Neucker K., Vanderstraeten G., De Muynck M., et al. The neurophysiologic examination in organophosphate ester poisoning. Case report and review of the literature. Electromyogr Clin Neurophysiol 31 (1991) 507-511
49. McConnell R., Delgado-Tellez E., Cuadra R., et al. Organophosphate neuropathy due to methamidophos: biochemical and neurophysiological markers. Arch Toxicol 73 (1999) 296-300
50. Akassoglou K., Malester B., Xu J., et al. Brain-specific deletion of neuropathy target esterase/swisscheese results in neurodegeneration. Proc Natl Acad Sci U S A 101 (2004) 5075-5080
51. Pace A., Bove L., Nistico C., et al. Vinorelbine neurotoxicity: clinical and neurophysiological findings in 23 patients. J Neurol Neurosurg Psychiatry 61 (1996) 409-411
52. Topp K.S., Tanner K.D., and Levine J.D. Damage to the cytoskeleton of large diameter sensory neurons and myelinated axons in vincristine-induced painful peripheral neuropathy in the rat. J Comp Neurol 424 (2000) 563-576
53. Nozaki-Taguchi N., Chaplan S.R., Higuera E.S., et al. Vincristine-induced allodynia in the rat. Pain 93 (2001) 69-76
54. Moudgil S.S., and Riggs J.E. Fulminant peripheral neuropathy with severe quadriparesis associated with vincristine therapy. Ann Pharmacother 34) (2000) 1136-1138
55. Chauvenet A.R., Shashi V., Selsky C., et al. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Pediatr Hematol Oncol 25 (2003) 316-320
56. Mercuri E., Poulton J., Buck J., et al. Vincristine treatment revealing asymptomatic hereditary motor sensory neuropathy type 1A. Arch Dis Child 81 (1999) 442-443
57. Orejana-Garcia A.M., Pascual-Huerta J., and Perez-Melero A. Charcot-Marie-Tooth disease and vincristine. J Am Podiatr Med Assoc 93 (2003) 229-233
58. Roelofs R.I., Hrushesky W., Rogin J., et al. Peripheral sensory neuropathy and cisplatin chemotherapy. Neurology 34 (1984) 934-938
59. Thompson S.W., Davis L.E., Kornfeld M., et al. Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies. Cancer 54 (1984) 1269-1275
60. Strumberg D., Brugge S., Korn M.W., et al. Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer. Ann Oncol 13 (2002) 229-236
61. Russell J.W., Windebank A.J., McNiven M.A., et al. Effect of cisplatin and ACTH4-9 on neural transport in cisplatin induced neurotoxicity. Brain Res 676 (1995) 258-267
62. McDonald E.S., and Windebank A.J. Cisplatin-induced apoptosis of DRG neurons involves bax redistribution and cytochrome c release but not fas receptor signaling. Neurobiol Dis 9 (2002) 220-233
63. Lheureux P., Penaloza A., and Gris M. Pyridoxine in clinical toxicology: a review. Eur J Emerg Med 12 (2005) 78-85
64. Schaumburg H., Kaplan J., Windebank A., et al. Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome. N Engl J Med 309 (1983) 445-448
65. Albin R.L., Albers J.W., Greenberg H.S., et al. Acute sensory neuropathy-neuronopathy from pyridoxine overdose. Neurology 37 (1987) 1729-1732
66. Moore D., House I., and Dixon A. Thallium poisoning. Diagnosis may be elusive but alopecia is the clue. BMJ 306 (1993) 1527-1529
67. Rangel-Guerra R., Martinez H.R., and Villarreal H.J. [Thallium poisoning. Experience with 50 patients]. Gac Med Mex 126 (1990) 487-494 [in Spanish]
68. Meggs W.J., Hoffman R.S., Shih R.D., et al. Thallium poisoning from maliciously contaminated food. J Toxicol Clin Toxicol 32 (1994) 723-730
69. Kubis N., Talamon C., Smadja D., et al. [Peripheral neuropathy caused by thallium poisoning]. Rev Neurol (Paris) 153 (1997) 599-601
70. Desenclos J.C., Wilder M.H., Coppenger G.W., et al. Thallium poisoning: an outbreak in Florida, 1988. South Med J 85 (1992) 1203-1206
71. Herrero F., Fernandez E., Gomez J., et al. Thallium poisoning presenting with abdominal colic, paresthesia, and irritability. J Toxicol Clin Toxicol 33 (1995) 261-264
72. Andersen O. Clinical evidence and therapeutic indications in neurotoxicology, exemplified by thallotoxicosis. Acta Neurol Scand Suppl 100 (1984) 185-192
73. Sharma A.N., Nelson L.S., and Hoffman R.S. Cerebrospinal fluid analysis in fatal thallium poisoning: evidence for delayed distribution into the central nervous system. Am J Forensic Med Pathol 25 (2004) 156-158
74. Pau P.W. Management of thallium poisoning. Hong Kong Med J 6 (2000) 316-318
75. Kuo H.C., Huang C.C., Tsai Y.T., et al. Acute painful neuropathy in thallium poisoning. Neurology 65 (2005) 302-304
76. Dumitru D., and Kalantri A. Electrophysiologic investigation of thallium poisoning. Muscle Nerve 13 (1990) 433-437
77. Hoffman R.S. Thallium toxicity and the role of Prussian blue in therapy. Toxicol Rev 22 (2003) 29-40
78. Lehane L. Paralytic shellfish poisoning: a potential public health problem. Med J Aust 175 (2001) 29-31
79. Wu J.Y., Zheng L., and Wang J.H. Contamination of shellfish from Shanghai seafood markets with paralytic shellfish poisoning and diarrhetic shellfish poisoning toxins determined by mouse bioassay and HPLC. Food Addit Contam 22 (2005) 647-651
80. de Carvalho M., Jacinto J., Ramos N., et al. Paralytic shellfish poisoning: clinical and electrophysiological observations. J Neurol 245 (1998) 551-554
81. Long R.R., Sargent J.C., and Hammer K. Paralytic shellfish poisoning: a case report and serial electrophysiologic observations. Neurology 40 (1990) 1310-1312
82. Isbister G.K., and Kiernan M.C. Neurotoxic marine poisoning. Lancet Neurol 4 (2005) 219-228
83. Kanchanapongkul J. Puffer fish poisoning: clinical features and management experience in 25 cases. J Med Assoc Thai 84 (2001) 385-389
84. Isbister G.K., Son J., Wang F., et al. Puffer fish poisoning: a potentially life-threatening condition. Med J Aust 177 (2002) 650-653
85. Oda K., Araki K., Totoki T., et al. Nerve conduction study of human tetrodotoxication. Neurology 39 (1989) 743-745
86. Friedman M. Chemistry, biochemistry, and safety of acrylamide. A review. J Agric Food Chem 51 (2003) 4504-4526
87. Mulloy K.B. Two case reports of neurological disease in coal mine preparation plant workers. Am J Ind Med 30 (1996) 56-61
88. Kjuus H., Goffeng L.O., Heier M.S., et al. Effects on the peripheral nervous system of tunnel workers exposed to acrylamide and N-methylolacrylamide. Scand J Work Environ Health 30 (2004) 21-29
89. Myers J.E., and Macun I. Acrylamide neuropathy in a South African factory: an epidemiologic investigation. Am J Ind Med 19 (1991) 487-493
90. Deng H., He F., Zhang S., Calleman C.J., et al. Quantitative measurements of vibration threshold in healthy adults and acrylamide workers. Int Arch Occup Environ Health 65 (1993) 53-56
91. Harris C.H., Gulati A.K., Friedman M.A., et al. Toxic neurofilamentous axonopathies and fast axonal transport. V. Reduced bidirectional vesicle transport in cultured neurons by acrylamide and glycidamide. J Toxicol Environ Health 42 (1994) 343-356
92. LoPachin R.M., Ross J.F., and Lehning E.J. Nerve terminals as the primary site of acrylamide action: a hypothesis. Neurotoxicology 23 (2002) 43-59
93. LoPachin R.M. Acrylamide neurotoxicity: neurological, morhological and molecular endpoints in animal models. Adv Exp Med Biol 561 (2005) 21-37
94. Jacknowitz A.I., Le Frock J.L., and Prince R.A. Nitrofurantoin polyneuropathy: report of two cases. Am J Hosp Pharm 34 (1977) 759-762
95. Yiannikas C., Pollard J.D., and McLeod J.G. Nitrofurantoin neuropathy. Aust N Z J Med 11 (1981) 400-405
96. Spielberg S.P., and Gordon G.B. Nitrofurantoin cytotoxicity. In vitro assessment of risk based on glutathione metabolism. J Clin Invest 67 (1981) 37-41
97. Lovelace R.E., and Horwitz S.J. Peripheral neuropathy in long-term diphenylhydantoin therapy. Trans Am Neurol Assoc 92 (1967) 262-264
98. Eisen A.A., Woods J.F., and Sherwin A.L. Peripheral nerve function in long-term therapy with diphenylhydantoin. A clinical and electrophysiologic correlation. Neurology 24 (1974) 411-417
99. Shorvon S.D., and Reynolds E.H. Anticonvulsant peripheral neuropathy: a clinical and electrophysiological study of patients on single drug treatment with phenytoin, carbamazepine or barbiturates. J Neurol Neurosurg Psychiatry 45 (1982) 620-626
100. Taylor J.W., Murphy M.J., and Rivey M.P. Clinical and electrophysiologic evaluation of peripheral nerve function in chronic phenytoin therapy. Epilepsia 26 (1985) 416-420
101. Swift T.R., Gross J.A., Ward L.C., et al. Peripheral neuropathy in epileptic patients. Neurology 31 (1981) 826-831
102. Bauer M., and Rabens S.F. Trichloroethylene toxicity. Int J Dermatol 16 (1977) 113-116
103. Buxton P.H., and Hayward M. Polyneuritis cranialis associated with industrial trichloroethylene poisoning. J Neurol Neurosurg Psychiatry 30 (1967) 511-518
104. Annau Z. The neurobehavioral toxicity of trichloroethylene. Neurobehav Toxicol Teratol 3 (1981) 417-424
105. Feldman R.G. Facial nerve latency studies in man: effects of trichlorethylene intoxication. Electromyography 10 (1970) 93-100
106. Feldman R.G., Chirico-Post J., and Proctor S.P. Blink reflex latency after exposure to trichloroethylene in well water. Arch Environ Health 43 (1988) 143-148
107. Laureno R. Trichloroethylene does not cause trigeminal neuropathy. Muscle Nerve 16 (1993) 217
108. Cavanagh J.B., and Buxton P.H. Trichloroethylene cranial neuropathy: is it really a toxic neuropathy or does it activate latent herpes virus?. J Neurol Neurosurg Psychiatry 52 (1989) 297-303
109. Rhodes L.E., Coleman M.D., and Lewis-Jones M.S. Dapsone-induced motor peripheral neuropathy in pemphigus foliaceus. Clin Exp Dermatol 20 (1995) 155-156
110. Rosen I., and Sornas R. Peripheral motor neuropathy caused by excessive intake of dapsone (Avlosulfon). Arch Psychiatr Nervenkr 232 (1982) 63-69
111. Koller W.C., Gehlmann L.K., Malkinson F.D., et al. Dapsone-induced peripheral neuropathy. Arch Neurol 34 (1977) 644-646
112. Gutmann L., Martin J.D., and Welton W. Dapsone motor neuropathy-an axonal disease. Neurology 26 6 PT 1 (1976) 514-516
113. Mery L., Dega H., Prost C., and Dubertret L. [Dapsone-induced sensory peripheral neuropathy]. Ann Dermatol Venereol 130 (2003) 447-449 [in French]
114. Ahrens E.M., Meckler R.J., and Callen J.P. Dapsone-induced peripheral neuropathy. Int J Dermatol 25 (1986) 314-316
115. Waldinger T.P., Siegle R.J., Weber W., et al. Dapsone-induced peripheral neuropathy. Case report and review. Arch Dermatol 120 (1984) 356-359
116. Sirsat A.M., Lalitha V.S., and Pandya S.S. Dapsone neuropathy-report of three cases and pathologic features of a motor nerve. Int J Lepr Other Mycobact Dis 55 (1987) 23-29
117. Hill A.B. The environment and disease: association or causation?. Proc R Soc Med 58 (1965) 295-300